136 related articles for article (PubMed ID: 18562440)
1. High-dose venlafaxine in delusional and severely depressed patients.
Ruiz-Doblado S; Rueda-Villar T; Casillas-Lara L
J Psychopharmacol; 2009 Sep; 23(7):859-60. PubMed ID: 18562440
[No Abstract] [Full Text] [Related]
2. Venlafaxine: loss of antidepressant effect and its management.
Sharma V
J Clin Psychiatry; 1998 Jul; 59(7):381-2. PubMed ID: 9714268
[No Abstract] [Full Text] [Related]
3. Effectiveness and safety of venlafaxine extended release in elderly depressed patients.
Ibor JJ; Carrasco JL; Prieto R; García-Calvo C;
Arch Gerontol Geriatr; 2008; 46(3):317-26. PubMed ID: 17617478
[TBL] [Abstract][Full Text] [Related]
4. Venlafaxine-mirtazapine combination in the treatment of persistent depressive illness.
Hannan N; Hamzah Z; Akinpeloye HO; Meagher D
J Psychopharmacol; 2007 Mar; 21(2):161-4. PubMed ID: 17329295
[TBL] [Abstract][Full Text] [Related]
5. Maintenance therapy to prevent recurrence of depression: summary and implications of the PREVENT study.
Kornstein SG
Expert Rev Neurother; 2008 May; 8(5):737-42. PubMed ID: 18457530
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effects of high dose venlafaxine XL in patients with major depressive disorder.
Mbaya P; Alam F; Ashim S; Bennett D
Hum Psychopharmacol; 2007 Apr; 22(3):129-33. PubMed ID: 17397100
[TBL] [Abstract][Full Text] [Related]
7. Changes in medial prefrontal cortex neural responses parallel successful antidepressant combination of venlafaxine and light therapy.
Benedetti F; Radaelli D; Bernasconi A; Dallaspezia S; Colombo C; Smeraldi E
Arch Ital Biol; 2009 Sep; 147(3):83-93. PubMed ID: 20014654
[TBL] [Abstract][Full Text] [Related]
8. Extended-release formulation of venlafaxine in the treatment of post-traumatic stress disorder.
Pae CU; Lim HK; Ajwani N; Lee C; Patkar AA
Expert Rev Neurother; 2007 Jun; 7(6):603-15. PubMed ID: 17563244
[TBL] [Abstract][Full Text] [Related]
9. [Not neglecting therapy of depression in the elderly].
MMW Fortschr Med; 2006 Apr; 148(16):56-7. PubMed ID: 16688953
[No Abstract] [Full Text] [Related]
10. Effects of venlafaxine extended release on resilience in posttraumatic stress disorder: an item analysis of the Connor-Davidson Resilience Scale.
Davidson J; Baldwin DS; Stein DJ; Pedersen R; Ahmed S; Musgnung J; Benattia I; Rothbaum BO
Int Clin Psychopharmacol; 2008 Sep; 23(5):299-303. PubMed ID: 18703940
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular changes associated with venlafaxine in the treatment of late-life depression.
Kok R; Nolen W; Heeren T
Am J Geriatr Psychiatry; 2007 Aug; 15(8):725; author reply 726. PubMed ID: 17670999
[No Abstract] [Full Text] [Related]
12. [Venlafaxine-containing prolonged release: critical exchange?].
Saussele T
Med Monatsschr Pharm; 2009 Jul; 32(7):239. PubMed ID: 19731750
[No Abstract] [Full Text] [Related]
13. Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode?
Amsterdam JD; Shults J
J Affect Disord; 2009 May; 115(1-2):234-40. PubMed ID: 18694599
[TBL] [Abstract][Full Text] [Related]
14. The influences of depression and venlafaxine use at therapeutic doses on atrial conduction.
Emul M; Dalkiran M; Samim S; Yildirim E; Bayar R; Balcioglu I; Keles I
J Psychopharmacol; 2009 Mar; 23(2):163-7. PubMed ID: 18515450
[TBL] [Abstract][Full Text] [Related]
15. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
[TBL] [Abstract][Full Text] [Related]
16. Adequacy of venlafaxine dose prescribing in major depression and hospital resources implications.
Vanoli A; Lane C; Harrison C; Steen N; Young A
J Psychopharmacol; 2008 Jun; 22(4):434-40. PubMed ID: 18635723
[TBL] [Abstract][Full Text] [Related]
17. Electroconvulsive therapy for lycanthropy and Cotard syndrome: a case report.
Grover S; Shah R; Ghosh A
J ECT; 2010 Dec; 26(4):280-1. PubMed ID: 20562636
[TBL] [Abstract][Full Text] [Related]
18. Psychological factors affecting response to antidepressant drugs in fibromyalgia.
Díaz-Marsá M; Palomares N; Morón MD; Tajima K; Fuentes ME; López-Ibor JJ; Carrasco JL
Psychosomatics; 2011; 52(3):237-44. PubMed ID: 21565595
[TBL] [Abstract][Full Text] [Related]
19. Dose-dependent Venlafaxine-induced sinus tachycardia.
Abozguia K; Chudley S; Gammage M
Int J Cardiol; 2006 Oct; 113(1):E9-10. PubMed ID: 16989912
[No Abstract] [Full Text] [Related]
20. Pneumonitis related to venlafaxine.
Vázquez MJ; Carretero Quevedo B
Psychosomatics; 2008; 49(1):84-5. PubMed ID: 18212183
[No Abstract] [Full Text] [Related]
[Next] [New Search]
